Bluejay Therapeutics Appoints Mary Cromwell as Senior Vice President and Head of Technical Operations
Bluejay’s lead product candidate brelovitug (BJT-778) recently received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic hepatitis delta (CHD).
Medindia1d
OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer
OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer ...
980 Prime Steakhouse - Loving Living Local
Impress your Valentine at 980 Prime Steakhouse at the Chamonix Casino Hotel in Cripple Creek. Enjoy great food, wine pairings, and a romantic setting.
Cadrenal Therapeutics Announces New Chief Medical Officer in Recent SEC Filing
Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025.